| 11001 | CLEC4D/HGF ratio | GCST90314110 | 2.30e-04 |
| 11002 | PLA2G4A/SPINT2 ratio | GCST90315671 | 2.29e-04 |
| 11003 | CD40/TIMP3 ratio | GCST90313829 | 2.29e-04 |
| 11004 | TNFRSF13B/TNFRSF13C ratio | GCST90315931 | 2.28e-04 |
| 11005 | EDAR/TMSB10 ratio | GCST90314590 | 2.27e-04 |
| 11006 | NAA80 levels | GCST90469990 | 2.27e-04 |
| 11007 | MME/NT5E ratio | GCST90315460 | 2.27e-04 |
| 11008 | CD38/IL12A_IL12B ratio | GCST90313808 | 2.26e-04 |
| 11009 | Cancer of prostate (PheCode 185) | GCST90475591 | 2.26e-04 |
| 11010 | CXCL17/LAMP3 ratio | GCST90314340 | 2.25e-04 |
| 11011 | SPARC/TACC3 ratio | GCST90315872 | 2.25e-04 |
| 11012 | aparc-a2009s rh area S-parieto-occipital | GCST90003435 | 2.24e-04 |
| 11013 | Qualifications - NVQ or HND or HNC or equivalent | Education | UKBB00000730 | 2.24e-04 |
| 11014 | Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers) | FING00000752 | 2.24e-04 |
| 11015 | SMOC2 levels | GCST90422773 | 2.24e-04 |
| 11016 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T32 | ECGU000032 | 2.24e-04 |
| 11017 | EIF4G1/NFATC1 ratio | GCST90314637 | 2.23e-04 |
| 11018 | Left-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302737 | 2.23e-04 |
| 11019 | aparc-DKTatlas lh area lingual | GCST90003245 | 2.22e-04 |
| 11020 | Asthma-related pneumonia | FING00000119 | 2.21e-04 |
| 11021 | Lymphoid neoplasms (B-cell phenocluster) | GCST90624736 | 2.20e-04 |
| 11022 | CCN2/SPINT2 ratio | GCST90313716 | 2.18e-04 |
| 11023 | TOR1AIP1 levels | GCST90470935 | 2.18e-04 |
| 11024 | PDGFB/PPP1R12A ratio | GCST90315623 | 2.18e-04 |
| 11025 | Varicose veins | FING00001416 | 2.18e-04 |
| 11026 | SPARC/TJAP1 ratio | GCST90315873 | 2.17e-04 |
| 11027 | ECG, heart rate | ECG during exercise | UKBB00000204 | 2.17e-04 |
| 11028 | ALB/Globulin ratio | UKBB00000020 | 2.16e-04 |
| 11029 | Asthma (childhood onset) | GCST007800 | 2.15e-04 |
| 11030 | IDP T1 FAST ROIs R cerebellum IX | GCST90002586 | 2.15e-04 |
| 11031 | C19ORF12 levels | GCST90468483 | 2.14e-04 |
| 11032 | Systolic blood pressure | GCST90472781 | 2.14e-04 |
| 11033 | CXADR/MME ratio | GCST90314329 | 2.13e-04 |
| 11034 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T22 | ECGU000022 | 2.13e-04 |
| 11035 | T1 FreeSurfer BA lh BA4p exvivo thickness | GCST90385524 | 2.12e-04 |
| 11036 | T1 FIRST volume BrStem | GCST90383989 | 2.11e-04 |
| 11037 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 12) | GCST90320831 | 2.11e-04 |
| 11038 | Attention deficit hyperactivity disorder (ADuLT model adjusted for sex) | GCST90275136 | 2.10e-04 |
| 11039 | Prostate cancer | GCST90274716 | 2.10e-04 |
| 11040 | aparc-Desikan lh area lingual | GCST90003085 | 2.10e-04 |
| 11041 | Cerebral aneurysm | GCST90018595 | 2.10e-04 |
| 11042 | Frequency of walking for pleasure in last 4 weeks | Physical activity | UKBB00000271 | 2.09e-04 |
| 11043 | GZMH/KLRD1 ratio | GCST90315016 | 2.08e-04 |
| 11044 | BIN2 levels | GCST90468445 | 2.07e-04 |
| 11045 | Body mass index (BMI, maximum, inv-normal transformed) | GCST90475153 | 2.07e-04 |
| 11046 | BACH1/PDLIM7 ratio | GCST90313445 | 2.06e-04 |
| 11047 | hemoglobin (mean, inv-norm transformed) | GCST90475374 | 2.06e-04 |
| 11048 | Symptoms involving digestive system (PheCode 561) | GCST90476069 | 2.05e-04 |
| 11049 | TJAP1 levels | GCST90470874 | 2.05e-04 |
| 11050 | Dry age-related macular degeneration (includes geographic atrophy) | FING00000480 | 2.05e-04 |
| 11051 | T1 FreeSurfer DKT rh lateraloccipital volume | GCST90384357 | 2.05e-04 |
| 11052 | lymphocyte (absolute count, minimum, inv-norm transformed) | GCST90475429 | 2.04e-04 |
| 11053 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 97) | GCST90320660 | 2.04e-04 |
| 11054 | CD20 on IgD- CD27- B cell | GCST90001754 | 2.04e-04 |
| 11055 | Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers) | FING00000751 | 2.03e-04 |
| 11056 | Operation code - inguinal hernia repair | Operations | UKBB00000560 | 2.03e-04 |
| 11057 | Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22) | GCST90475991 | 2.03e-04 |
| 11058 | Psoriasis vulgaris | FING00001224 | 2.02e-04 |
| 11059 | Glucose levels | GCST90132724 | 2.02e-04 |
| 11060 | Prostate cancer | GCST90475185 | 2.02e-04 |
| 11061 | Basal cell carcinoma (PheCode 172.21) | GCST90475582 | 2.01e-04 |
| 11062 | X-21353 metabolite level | GCST90616708 | 2.01e-04 |
| 11063 | Back pain (PheCode 760) | GCST90476266 | 2.01e-04 |
| 11064 | MSTN/RGMA ratio | GCST90315504 | 2.01e-04 |
| 11065 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T68 | ECGA000068 | 2.00e-04 |
| 11066 | SIRT1 levels | GCST90470641 | 2.00e-04 |
| 11067 | HippSubfield rh volume presubiculum-body | GCST90002697 | 2.00e-04 |
| 11068 | Right-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302845 | 1.99e-04 |
| 11069 | Fractured bone site(s) - Wrist | Medical conditions | UKBB00000257 | 1.99e-04 |
| 11070 | AmygNuclei rh volume Accessory-Basal-nucleus | GCST90002660 | 1.99e-04 |
| 11071 | CA2/PSMG3 ratio | GCST90313581 | 1.99e-04 |
| 11072 | GZMA levels | GCST90241323 | 1.99e-04 |
| 11073 | Chronic obstructive pulmonary disease in never smokers | GCST90016589 | 1.99e-04 |
| 11074 | T1 FreeSurfer aseg Right-Caudate | GCST90384162 | 1.99e-04 |
| 11075 | IDP dMRI ProbtrackX ISOVF slf l | GCST90004546 | 1.98e-04 |
| 11076 | CD69/EDAR ratio | GCST90313875 | 1.98e-04 |
| 11077 | Charcot foot | FING00000268 | 1.97e-04 |
| 11078 | LAT/LYN ratio | GCST90315283 | 1.96e-04 |
| 11079 | Ulcerative colitis | GCST90468152 | 1.96e-04 |
| 11080 | TFF1 levels | GCST90470835 | 1.95e-04 |
| 11081 | T1 FreeSurfer DK rh superiorparietal thickness | GCST90385751 | 1.93e-04 |
| 11082 | Takes medication for asthma? | GCST90475260 | 1.93e-04 |
| 11083 | Graves' disease (PheCode 242.1) | GCST90475644 | 1.92e-04 |
| 11084 | Cough (PheCode 512.8) | GCST90476041 | 1.92e-04 |
| 11085 | Pork consumption | GCST90132999 | 1.92e-04 |
| 11086 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T447 | ECGA000447 | 1.91e-04 |
| 11087 | Nephrotic syndrome | GCST90018664 | 1.91e-04 |
| 11088 | eosinophil (absolute count, maximum, inv-norm transformed) | GCST90475288 | 1.91e-04 |
| 11089 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000808 | 1.90e-04 |
| 11090 | aparc-pial lh area postcentral | GCST90003162 | 1.90e-04 |
| 11091 | Volume of right whole amygdala | GCST90475057 | 1.90e-04 |
| 11092 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39) | GCST90320858 | 1.90e-04 |
| 11093 | FXYD5/TMSB10 ratio | GCST90314906 | 1.90e-04 |
| 11094 | Ever depressed for a whole week | Mental health | UKBB00000214 | 1.89e-04 |
| 11095 | SHBG levels | GCST90470622 | 1.89e-04 |
| 11096 | PPP1R14A levels | GCST90470302 | 1.87e-04 |
| 11097 | Other specified disorders of external ear | FING00001104 | 1.87e-04 |
| 11098 | Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000804 | 1.87e-04 |
| 11099 | Ceramide (d16:1/22:0) levels | GCST90024026 | 1.86e-04 |
| 11100 | CD84/SDC4 ratio | GCST90313916 | 1.86e-04 |
| 11101 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T450 | ECGA000450 | 1.85e-04 |
| 11102 | wg lh intensity-contrast cuneus | GCST90003796 | 1.85e-04 |
| 11103 | Mosaic chromosomal alteration of the X chromosome | GCST90165287 | 1.84e-04 |
| 11104 | X-12510--2-aminooctanoic acid levels | GCST90243748 | 1.84e-04 |
| 11105 | Mouth/teeth dental problems - Bleeding gums | Mouth | UKBB00000485 | 1.83e-04 |
| 11106 | Basophil count | GCST90002293 | 1.82e-04 |
| 11107 | NQO2 levels | GCST90242679 | 1.82e-04 |
| 11108 | Principal component-derived dietary pattern 10 | GCST90133015 | 1.81e-04 |
| 11109 | Cardiovascular diseases (excluding rheumatic etc) | FING00000255 | 1.81e-04 |
| 11110 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36) | GCST90320599 | 1.80e-04 |
| 11111 | Ulcerative enterocolitis | FING00001391 | 1.80e-04 |
| 11112 | PLA2G2A levels | GCST90470247 | 1.80e-04 |
| 11113 | NFATC3 levels | GCST90470034 | 1.79e-04 |
| 11114 | EIF4G1/FOXO1 ratio | GCST90314634 | 1.79e-04 |
| 11115 | Self-reported risk-taking behaviour | GCST006810 | 1.79e-04 |
| 11116 | JAM2/TNFRSF19 ratio | GCST90315241 | 1.78e-04 |
| 11117 | Usual side of head for mobile phone use - Equally left and right | Electronic device use | UKBB00000888 | 1.78e-04 |
| 11118 | Cysteine-glutathione disulfide levels | GCST90199784 | 1.78e-04 |
| 11119 | Handedness (confirmatory factor analysis Factor 36) | GCST90309370 | 1.78e-04 |
| 11120 | Mean platelet volume during second trimester of pregnancy | GCST90302230 | 1.78e-04 |
| 11121 | Mid-point of the five least active hours of the day | GCST90061434 | 1.76e-04 |
| 11122 | Type 1 diabetes with neurological manifestations (PheCode 250.14) | GCST90475664 | 1.75e-04 |
| 11123 | First line medication for Crohn's disease | FING00000544 | 1.75e-04 |
| 11124 | SERPINB6/TXNDC5 ratio | GCST90315832 | 1.74e-04 |
| 11125 | Left-hemisphere salience/ventral attention network to right-hemisphere control network white-matter structural connectivity | GCST90302717 | 1.74e-04 |
| 11126 | F-sodas liking (derived food-liking factor) | GCST90094842 | 1.73e-04 |
| 11127 | Right-hemisphere somatomotor network to caudate white-matter structural connectivity | GCST90302795 | 1.72e-04 |
| 11128 | Number of sexual partners in opposite-sex sexual behavior | GCST90026480 | 1.72e-04 |
| 11129 | Gastric cancer | GCST90018629 | 1.72e-04 |
| 11130 | Asthma and allergy | FING00000115 | 1.72e-04 |
| 11131 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426 | ECGU000426 | 1.72e-04 |
| 11132 | aparc-a2009s rh volume S-postcentral | GCST90003065 | 1.71e-04 |
| 11133 | Right-hemisphere limbic network to putamen white-matter structural connectivity | GCST90302829 | 1.71e-04 |
| 11134 | Glaucoma | GCST90475869 | 1.71e-04 |
| 11135 | DUSP3 levels | GCST90469053 | 1.70e-04 |
| 11136 | BOLA2 or BOLA2B levels | GCST90468460 | 1.70e-04 |
| 11137 | PDGFB/SNAP29 ratio | GCST90315627 | 1.70e-04 |
| 11138 | Length of mobile phone use | Electronic device use | UKBB00000403 | 1.69e-04 |
| 11139 | PPP1R2/TACC3 ratio | GCST90315719 | 1.69e-04 |
| 11140 | Radiotherapy (PheCode 196) | GCST90475605 | 1.68e-04 |
| 11141 | IKBKG levels | GCST90469542 | 1.67e-04 |
| 11142 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T259 | ECGA000259 | 1.67e-04 |
| 11143 | CETN2 levels | GCST90468721 | 1.67e-04 |
| 11144 | F-vegetarian liking (derived food-liking factor) | GCST90094863 | 1.66e-04 |
| 11145 | Basophil percentage of white cells | GCST004631 | 1.65e-04 |
| 11146 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T270 | ECGU000270 | 1.65e-04 |
| 11147 | Dissociative [conversion] disorders | FING00000468 | 1.65e-04 |
| 11148 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320895 | 1.65e-04 |
| 11149 | CHMP1A levels | GCST90619002 | 1.65e-04 |
| 11150 | DNAJA2/SCAMP3 ratio | GCST90314507 | 1.64e-04 |
| 11151 | Vitamin B12 deficiency anaemia | FING00001441 | 1.64e-04 |
| 11152 | Respiratory disease (confirmatory factor analysis Factor 11) | GCST90309345 | 1.64e-04 |
| 11153 | KLRB1 levels | GCST90469709 | 1.64e-04 |
| 11154 | Radial styloid tenosynovitis [de Quervain] | FING00001237 | 1.64e-04 |
| 11155 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T269 | ECGU000269 | 1.63e-04 |
| 11156 | Treatment/medication code - atenolol | Medications | UKBB00000842 | 1.63e-04 |
| 11157 | APCS levels | GCST90428463 | 1.62e-04 |
| 11158 | IL6 expression at 6 weeks in whole blood upon Bbmix moi30 stimulation in Lyme borreliosis | GCST90275789 | 1.62e-04 |
| 11159 | Patient classification on admission (recoded) - Day case | Summary Administration | UKBB00000636 | 1.62e-04 |
| 11160 | Depression medications | FING00000399 | 1.61e-04 |
| 11161 | EBAG9/EDAR ratio | GCST90314563 | 1.61e-04 |
| 11162 | Prescriptions - lipase inhibitor|obesity | UKBB00000688 | 1.61e-04 |
| 11163 | Prescriptions - orlistat | lipase inhibitor,obesity | UKBB00000695 | 1.61e-04 |
| 11164 | EDAR/PSRC1 ratio | GCST90314584 | 1.60e-04 |
| 11165 | IDP dMRI ProbtrackX OD slf r | GCST90004472 | 1.60e-04 |
| 11166 | GET3 levels | GCST90469324 | 1.60e-04 |
| 11167 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T435 | ECGA000435 | 1.59e-04 |
| 11168 | IDP dMRI TBSS L1 Uncinate fasciculus L | GCST90004120 | 1.59e-04 |
| 11169 | Hypothyroidism, drug reimbursement | FING00000655 | 1.57e-04 |
| 11170 | Right-hemisphere dorsal attention network to amygdala white-matter structural connectivity | GCST90302811 | 1.57e-04 |
| 11171 | Otitis externa | FING00001128 | 1.56e-04 |
| 11172 | Type 2 diabetes | GCST010118 | 1.55e-04 |
| 11173 | Volume of left anterior amygdaloid area | GCST90474937 | 1.54e-04 |
| 11174 | Urine methylsuccinoylcarnitine levels in chronic kidney disease | GCST90265509 | 1.54e-04 |
| 11175 | Ulcerative colitis | GCST90476067 | 1.53e-04 |
| 11176 | Certain disorders involving the immune mechanism | FING00000264 | 1.52e-04 |
| 11177 | Hypertension (confirmatory factor analysis Factor 12) | GCST90309346 | 1.52e-04 |
| 11178 | Pilonidal cyst | FING00001167 | 1.51e-04 |
| 11179 | Antihypertensive medication - note that there are other indications | FING00000097 | 1.51e-04 |
| 11180 | Pulse pressure (BMI unadjusted) | GCST90335166 | 1.51e-04 |
| 11181 | Basophil count | GCST90018726 | 1.50e-04 |
| 11182 | Intended management of patient (recoded) - No overnight hospital stay | Summary Administration | UKBB00000366 | 1.49e-04 |
| 11183 | SCRG1 levels | GCST90470554 | 1.49e-04 |
| 11184 | CEP43/PLXNB3 ratio | GCST90314020 | 1.49e-04 |
| 11185 | BA-exvivo rh area BA45 | GCST90003229 | 1.48e-04 |
| 11186 | F-carbohydrate liking (derived food-liking factor) | GCST90094725 | 1.48e-04 |
| 11187 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T50 | ECGU000050 | 1.48e-04 |
| 11188 | DARS1/EIF4B ratio | GCST90314403 | 1.48e-04 |
| 11189 | Medication use (glucocorticoids) | GCST90018780 | 1.48e-04 |
| 11190 | DHX58 levels | GCST90618238 | 1.48e-04 |
| 11191 | NPDC1 levels | GCST90470069 | 1.47e-04 |
| 11192 | ADH4/CA5A ratio | GCST90313189 | 1.47e-04 |
| 11193 | DKK1/VEGFA ratio | GCST90314483 | 1.47e-04 |
| 11194 | Asthma | GCST90014325 | 1.47e-04 |
| 11195 | COMMD1 levels | GCST90468825 | 1.46e-04 |
| 11196 | Acute appendicitis, no complications | FING00000018 | 1.46e-04 |
| 11197 | IDP dMRI ProbtrackX ISOVF unc l | GCST90004550 | 1.46e-04 |
| 11198 | aparc-Desikan rh volume precuneus | GCST90002825 | 1.46e-04 |
| 11199 | High blood pressure / hypertension | GCST90475214 | 1.46e-04 |
| 11200 | PIBF1 levels | GCST90470231 | 1.45e-04 |
| 11201 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T99 | ECGA000099 | 1.45e-04 |
| 11202 | Cardiac arrhythmias | FING00000248 | 1.45e-04 |
| 11203 | Anomalies of dental arch relationship, including avohilmo | FING00000091 | 1.45e-04 |
| 11204 | Coeliac disease | FING00000312 | 1.44e-04 |
| 11205 | IDP dMRI ProbtrackX MD fmi | GCST90004230 | 1.44e-04 |
| 11206 | Diseases of white blood cells (PheCode 288) | GCST90475812 | 1.44e-04 |
| 11207 | Blood cell traits latent factor 3 (white cell) | GCST90559245 | 1.44e-04 |
| 11208 | Psoriasis (PheCode 696.4) | GCST90476187 | 1.43e-04 |
| 11209 | CDH1/CST3 ratio | GCST90313946 | 1.43e-04 |
| 11210 | Body mass index (BMI, minimum, inv-normal transformed) | GCST90475159 | 1.42e-04 |
| 11211 | Cataracts | GCST90018594 | 1.42e-04 |
| 11212 | AGT levels | GCST90468257 | 1.41e-04 |
| 11213 | IDP dMRI ProbtrackX L2 ifo r | GCST90004286 | 1.41e-04 |
| 11214 | Atopic dermatitis | GCST90027161 | 1.41e-04 |
| 11215 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320905 | 1.40e-04 |
| 11216 | IDP dMRI TBSS L1 Body of corpus callosum | GCST90004078 | 1.39e-04 |
| 11217 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T441 | ECGA000441 | 1.39e-04 |
| 11218 | CD5/CD6 ratio | GCST90313860 | 1.38e-04 |
| 11219 | GKN1 levels | GCST90469353 | 1.37e-04 |
| 11220 | Plasma propionylcarnitine (C3) levels in chronic kidney disease | GCST90265876 | 1.37e-04 |
| 11221 | ESR1 levels | GCST90469155 | 1.37e-04 |
| 11222 | IDP dMRI ProbtrackX L1 unc l | GCST90004271 | 1.36e-04 |
| 11223 | ITGAL levels | GCST90469637 | 1.36e-04 |
| 11224 | IL15 levels | GCST90469556 | 1.35e-04 |
| 11225 | Melanomas of skin, dx or hx (PheCode 172.1) | GCST90475577 | 1.35e-04 |
| 11226 | DBI/MESD ratio | GCST90314409 | 1.35e-04 |
| 11227 | rfMRI connectivity (ICA100 edge 1011) | GCST90005864 | 1.34e-04 |
| 11228 | Cardiorespiratory fitness (vo2 max) | GCST90093316 | 1.34e-04 |
| 11229 | Overweight, obesity and other hyperalimentation (PheCode 278) | GCST90475759 | 1.34e-04 |
| 11230 | Senile cataract | FING00001290 | 1.33e-04 |
| 11231 | lymphocyte (absolute count, mean, inv-norm transformed) | GCST90475426 | 1.33e-04 |
| 11232 | Vitiligo | FING00001443 | 1.33e-04 |
| 11233 | Thyrotoxicosis with or without goiter (PheCode 242) | GCST90475643 | 1.33e-04 |
| 11234 | Glaucoma | GCST90475383 | 1.33e-04 |
| 11235 | CD3 on Terminally Differentiated CD4+ T cell | GCST90001844 | 1.33e-04 |
| 11236 | Left ventricular outflow tract obstruction (LVOTO), broad definition | FING00000717 | 1.32e-04 |
| 11237 | DTI autoptx MD str r tract | GCST90385244 | 1.32e-04 |
| 11238 | Vertical cup-disc ratio | GCST004075 | 1.31e-04 |
| 11239 | Soft cheese liking | GCST90094843 | 1.31e-04 |
| 11240 | Asthma/COPD (KELA code 203) | FING00000121 | 1.31e-04 |
| 11241 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T449 | ECGA000449 | 1.30e-04 |
| 11242 | Length of working week for main job | Employment | UKBB00000405 | 1.30e-04 |
| 11243 | Duration of vigorous activity | Physical activity | UKBB00000199 | 1.29e-04 |
| 11244 | Right-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302828 | 1.29e-04 |
| 11245 | Degenerative skin conditions and other dermatoses (PheCode 702) | GCST90476202 | 1.28e-04 |
| 11246 | COPD | FING00000350 | 1.28e-04 |
| 11247 | Never eat wheat vs no wheat restrictions (UKB data field 6144) | GCST90132932 | 1.28e-04 |
| 11248 | Sicca syndrome [Sjögren] | FING00001304 | 1.27e-04 |
| 11249 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T442 | ECGA000442 | 1.27e-04 |
| 11250 | IFNG levels | GCST90469515 | 1.27e-04 |
| 11251 | ADM levels | GCST90011996 | 1.26e-04 |
| 11252 | CA6/DNER ratio | GCST90313594 | 1.26e-04 |
| 11253 | LIPF levels | GCST90469780 | 1.25e-04 |
| 11254 | Ulcerative colitis (strict definition, require KELA, min 2 HDR) | FING00001388 | 1.25e-04 |
| 11255 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T430 | ECGA000430 | 1.25e-04 |
| 11256 | IDP dMRI TBSS L3 Posterior thalamic radiation L | GCST90004200 | 1.25e-04 |
| 11257 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65) | GCST90320884 | 1.25e-04 |
| 11258 | ARHGAP30 levels | GCST90468354 | 1.23e-04 |
| 11259 | CDC27 levels | GCST90468664 | 1.23e-04 |
| 11260 | Ever sought or received professional help for mental distress | Mental distress | UKBB00000222 | 1.23e-04 |
| 11261 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T42 | ECGU000042 | 1.23e-04 |
| 11262 | hematocrit (maximum, inv-norm transformed) | GCST90475338 | 1.23e-04 |
| 11263 | Cerebrovascular disease (PheCode 433) | GCST90475985 | 1.22e-04 |
| 11264 | Waist circumference | GCST90278648 | 1.22e-04 |
| 11265 | VSTM2L levels | GCST90471057 | 1.21e-04 |
| 11266 | Disorders of vestibular function (Vertigo) | FING00000464 | 1.21e-04 |
| 11267 | Takes medication for Thyroid problems? | GCST90475277 | 1.20e-04 |
| 11268 | ACE2/MME ratio | GCST90313154 | 1.20e-04 |
| 11269 | SNAP25 levels | GCST90422083 | 1.19e-04 |
| 11270 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T432 | ECGU000432 | 1.19e-04 |
| 11271 | Non-allergic asthma (mode) (more control exclusions) | FING00000869 | 1.19e-04 |
| 11272 | SERPINB1/SERPINB6 ratio | GCST90315826 | 1.19e-04 |
| 11273 | IDP dMRI ProbtrackX L2 fmi | GCST90004284 | 1.19e-04 |
| 11274 | Diseases of oesophagus, stomach and duodenum | FING00000428 | 1.18e-04 |
| 11275 | Medication use (drugs affecting bone structure and mineralization) | GCST90018773 | 1.18e-04 |
| 11276 | ELOA/POLR2F ratio | GCST90314643 | 1.18e-04 |
| 11277 | Asthma | GCST90468112 | 1.17e-04 |
| 11278 | CD1C levels | GCST90468604 | 1.17e-04 |
| 11279 | GFRA1 levels | GCST90469328 | 1.16e-04 |
| 11280 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16) | GCST90320579 | 1.16e-04 |
| 11281 | DTI autoptx MD fma tract | GCST90385230 | 1.15e-04 |
| 11282 | CD27 levels | GCST90468615 | 1.15e-04 |
| 11283 | CD2AP levels | GCST90468617 | 1.15e-04 |
| 11284 | Other and unspecified tonsillitis | FING00000954 | 1.14e-04 |
| 11285 | Tibiofemoral angle | GCST90270263 | 1.14e-04 |
| 11286 | KITLG levels | GCST90274833 | 1.14e-04 |
| 11287 | Excessive, frequent and irregular menstruation | FING00000524 | 1.14e-04 |
| 11288 | CDSN/WFDC12 ratio | GCST90313999 | 1.13e-04 |
| 11289 | Left-hemisphere limbic network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302731 | 1.13e-04 |
| 11290 | T1 FreeSurfer a2009s lh G cuneus area | GCST90384678 | 1.13e-04 |
| 11291 | Skin cancer | GCST90475189 | 1.13e-04 |
| 11292 | Other anxiety disorders | FING00000960 | 1.13e-04 |
| 11293 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79) | GCST90320898 | 1.13e-04 |
| 11294 | pro-brain natriuretic peptide (proBNP, mean, inv-norm transformed) | GCST90476312 | 1.13e-04 |
| 11295 | SULT2A1 levels | GCST90470782 | 1.13e-04 |
| 11296 | Normal-pressure hydrocephalus | FING00000891 | 1.12e-04 |
| 11297 | Systolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000805 | 1.12e-04 |
| 11298 | BCR/ITGB1BP2 ratio | GCST90313494 | 1.12e-04 |
| 11299 | FUT8/SPARC ratio | GCST90314893 | 1.12e-04 |
| 11300 | Pulse pressure (BMI adjusted) | GCST90335167 | 1.12e-04 |
| 11301 | MAVS/ZBTB16 ratio | GCST90315401 | 1.11e-04 |
| 11302 | eosinophil (absolute count, mean, inv-norm transformed) | GCST90475291 | 1.11e-04 |
| 11303 | T1 FreeSurfer DKT rh lingual area | GCST90384297 | 1.10e-04 |
| 11304 | GCHFR levels | GCST90469317 | 1.10e-04 |
| 11305 | HippSubfield rh volume CA4-head | GCST90002704 | 1.10e-04 |
| 11306 | Rheumatoid arthritis and other inflammatory (PheCode 714) | GCST90476228 | 1.10e-04 |
| 11307 | METAP1D/VASH1 ratio | GCST90315429 | 1.09e-04 |
| 11308 | Psoriasis and related disorder (PheCode 696) | GCST90476186 | 1.09e-04 |
| 11309 | Arachidoylcarnitine (C20) levels | GCST90200135 | 1.09e-04 |
| 11310 | TNFRSF13B/TNFRSF9 ratio | GCST90315932 | 1.09e-04 |
| 11311 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T38 | ECGU000038 | 1.08e-04 |
| 11312 | Left-hemisphere default mode network to hippocampus white-matter structural connectivity | GCST90302771 | 1.08e-04 |
| 11313 | IDP dMRI ProbtrackX L2 ptr l | GCST90004292 | 1.08e-04 |
| 11314 | Eye problems/disorders - None of the above | Eyesight | UKBB00000232 | 1.08e-04 |
| 11315 | APP/TMSB10 ratio | GCST90313332 | 1.07e-04 |
| 11316 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63 | ECGA000063 | 1.07e-04 |
| 11317 | IFI30 levels | GCST90469509 | 1.07e-04 |
| 11318 | SERPINA6 levels | GCST90470586 | 1.06e-04 |
| 11319 | CDSN/LY6D ratio | GCST90313997 | 1.06e-04 |
| 11320 | IDP dMRI ProbtrackX FA ifo r | GCST90003938 | 1.06e-04 |
| 11321 | T1 FreeSurfer DK rh lingual area | GCST90385701 | 1.06e-04 |
| 11322 | KLK11 levels | GCST90012012 | 1.06e-04 |
| 11323 | Intelligence | GCST006250 | 1.05e-04 |
| 11324 | Congenital malformations of heart and great arteries | FING00000336 | 1.05e-04 |
| 11325 | Physical activity (Total log acceleration 6am-8am) | GCST90061412 | 1.04e-04 |
| 11326 | Diastolic blood pressure (MTAG) | GCST90449057 | 1.03e-04 |
| 11327 | Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers) | FING00001143 | 1.03e-04 |
| 11328 | Other noninfective gastroenteritis and colitis | FING00001077 | 1.02e-04 |
| 11329 | Atopic dermatitis | FING00000125 | 1.02e-04 |
| 11330 | CCN2/VEGFC ratio | GCST90313719 | 1.02e-04 |
| 11331 | HippSubfield rh volume Hippocampal-tail | GCST90002690 | 1.02e-04 |
| 11332 | DNMBP levels | GCST90469023 | 1.02e-04 |
| 11333 | MGLL/MITD1 ratio | GCST90315436 | 1.02e-04 |
| 11334 | Late-onset myasthenia gravis | GCST90093466 | 1.01e-04 |
| 11335 | Volume of left lateral nucleus | GCST90474970 | 1.01e-04 |
| 11336 | CXCL12/TIMP3 ratio | GCST90314338 | 1.01e-04 |
| 11337 | HippSubfield rh volume molecular-layer-HP-head | GCST90002699 | 1.01e-04 |
| 11338 | LPCAT2 levels | GCST90469787 | 9.99e-05 |
| 11339 | aparc-DKTatlas rh volume precuneus | GCST90002916 | 9.99e-05 |
| 11340 | Blepharochalasis | FING00000220 | 9.95e-05 |
| 11341 | HSPB6 levels | GCST90469490 | 9.95e-05 |
| 11342 | EIF4G1/FKBP5 ratio | GCST90314633 | 9.94e-05 |
| 11343 | MAVS levels | GCST90469866 | 9.92e-05 |
| 11344 | Hypertensive heart and/or renal disease (PheCode 401.2) | GCST90475924 | 9.89e-05 |
| 11345 | Mouth/teeth dental problems - None of the above | Mouth | UKBB00000489 | 9.83e-05 |
| 11346 | Infective dermatitis | FING00000673 | 9.82e-05 |
| 11347 | RAP1A levels | GCST90470425 | 9.76e-05 |
| 11348 | Gastroduodenal ulcer | FING00000565 | 9.72e-05 |
| 11349 | KLK14 levels | GCST90469700 | 9.71e-05 |
| 11350 | Systolic blood pressure (MTAG) | GCST90449056 | 9.70e-05 |
| 11351 | Low back pain | FING00000730 | 9.69e-05 |
| 11352 | Non-cancer illness code, self-reported - glaucoma | Medical conditions | UKBB00000511 | 9.66e-05 |
| 11353 | Asthma (adult onset) | GCST007799 | 9.66e-05 |
| 11354 | Systolic blood pressure (UKB data field 4080) | GCST90468179 | 9.65e-05 |
| 11355 | IDP dMRI ProbtrackX L3 unc l | GCST90004325 | 9.64e-05 |
| 11356 | Cauliflower liking | GCST90094727 | 9.60e-05 |
| 11357 | SERPINA7 levels | GCST90470587 | 9.55e-05 |
| 11358 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T294 | ECGU000294 | 9.49e-05 |
| 11359 | Asthma | GCST010042 | 9.49e-05 |
| 11360 | aparc-Desikan lh area postcentral | GCST90003094 | 9.49e-05 |
| 11361 | Asthma (more control exclusions) | FING00000113 | 9.48e-05 |
| 11362 | CD55/CHI3L1 ratio | GCST90313845 | 9.44e-05 |
| 11363 | Seborrhoeic keratosis | FING00001283 | 9.43e-05 |
| 11364 | EDAR levels | GCST90469068 | 9.43e-05 |
| 11365 | Psoriasis vulgaris (PheCode 696.41) | GCST90476190 | 9.40e-05 |
| 11366 | PPP1R12A/SKAP2 ratio | GCST90315710 | 9.38e-05 |
| 11367 | HYAL1 levels | GCST90469495 | 9.38e-05 |
| 11368 | NBN levels | GCST90470002 | 9.34e-05 |
| 11369 | Endometriosis of rectovaginal septum and vagina | FING00000503 | 9.33e-05 |
| 11370 | PLXNB2/SEMA7A ratio | GCST90315692 | 9.30e-05 |
| 11371 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 14) | GCST90320577 | 9.27e-05 |
| 11372 | Urine glucosaminate levels in chronic kidney disease | GCST90265179 | 9.24e-05 |
| 11373 | Fracture of upper limb (PheCode 803) | GCST90476279 | 9.24e-05 |
| 11374 | TNFRSF9 levels | GCST90470916 | 9.21e-05 |
| 11375 | Other bacterial diseases | FING00000968 | 9.12e-05 |
| 11376 | TBC1D23 levels | GCST90470810 | 9.08e-05 |
| 11377 | aparc-pial rh area parsopercularis | GCST90003191 | 9.07e-05 |
| 11378 | ATXN2L levels | GCST90468402 | 9.04e-05 |
| 11379 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T293 | ECGU000293 | 9.02e-05 |
| 11380 | SMOC2 levels | GCST90060059 | 9.02e-05 |
| 11381 | ADAMTS16 levels | GCST90468224 | 8.99e-05 |
| 11382 | Systolic blood pressure | GCST90310294 | 8.97e-05 |
| 11383 | Takes medication for Skin condition (ex. Eczema, Psoriasis)? | GCST90475275 | 8.97e-05 |
| 11384 | ANXA3/EDAR ratio | GCST90313280 | 8.97e-05 |
| 11385 | INSL5 levels | GCST90469622 | 8.91e-05 |
| 11386 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90025434 | 8.91e-05 |
| 11387 | EXTL1 levels | GCST90469161 | 8.86e-05 |
| 11388 | LAYN/PTPRN2 ratio | GCST90315290 | 8.84e-05 |
| 11389 | Job involved shift work | Employment history | UKBB00000382 | 8.82e-05 |
| 11390 | Breast cancer (estrogen-receptor negative) | GCST005076 | 8.81e-05 |
| 11391 | Nervonoylcarnitine (C24:1) levels | GCST90200143 | 8.78e-05 |
| 11392 | SEMA3G levels | GCST90242746 | 8.75e-05 |
| 11393 | DRAXIN levels | GCST90469038 | 8.72e-05 |
| 11394 | CPXM2 levels | GCST90468850 | 8.64e-05 |
| 11395 | Operation code - coronary angioplasty (ptca) +/- stent | Operations | UKBB00000555 | 8.64e-05 |
| 11396 | Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers) | FING00000764 | 8.63e-05 |
| 11397 | neutrophil (fraction, maximum, inv-norm transformed) | GCST90475535 | 8.62e-05 |
| 11398 | IL1R2/MEGF9 ratio | GCST90315159 | 8.61e-05 |
| 11399 | Glomerular diseases | FING00000581 | 8.58e-05 |
| 11400 | Methods of discharge from hospital (recoded) - Discharged on clinical advice/consent | Summary Administration | UKBB00000466 | 8.57e-05 |
| 11401 | Birth year infant mortality rates | GCST90095047 | 8.56e-05 |
| 11402 | Prescriptions - paracetamol | antipyretic | UKBB00000696 | 8.56e-05 |
| 11403 | Prescriptions - antipyretic | UKBB00000665 | 8.56e-05 |
| 11404 | CCL16 levels | GCST90468568 | 8.55e-05 |
| 11405 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T37 | ECGU000037 | 8.54e-05 |
| 11406 | DDR1/SFTPD ratio | GCST90314443 | 8.51e-05 |
| 11407 | Early-onset myasthenia gravis | GCST90093465 | 8.51e-05 |
| 11408 | Diseases of external ear | FING00000424 | 8.50e-05 |
| 11409 | SERPINI1 levels | GCST90470602 | 8.43e-05 |
| 11410 | IDP dMRI ProbtrackX FA ptr r | GCST90003945 | 8.42e-05 |
| 11411 | Diastolic blood pressure | GCST90472778 | 8.41e-05 |
| 11412 | CDSN/KLK8 ratio | GCST90313996 | 8.40e-05 |
| 11413 | MAVS/SCAMP3 ratio | GCST90315396 | 8.36e-05 |
| 11414 | Glucose levels (UKB data field 30740) | GCST90468071 | 8.33e-05 |
| 11415 | IDP T1 FAST ROIs L thalamus | GCST90002547 | 8.31e-05 |
| 11416 | Non-seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00000874 | 8.24e-05 |
| 11417 | T1 FreeSurfer DK rh lateraloccipital volume | GCST90385767 | 8.19e-05 |
| 11418 | Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensive | UKBB00000660 | 8.18e-05 |
| 11419 | DAB2/FKBP1B ratio | GCST90314362 | 8.16e-05 |
| 11420 | Annual healthcare cost | GCST90292604 | 8.13e-05 |
| 11421 | aparc-DKTatlas lh volume precuneus | GCST90002885 | 8.11e-05 |
| 11422 | Chronic lower respiratory diseases | FING00000290 | 8.09e-05 |
| 11423 | eosinophil (absolute count, minimum, inv-norm transformed) | GCST90475294 | 7.97e-05 |
| 11424 | PM: initial answer - Orange circle| Prospective memory | UKBB00000652 | 7.90e-05 |
| 11425 | ICD10 O14: Pre-eclampsia | GCST90454233 | 7.89e-05 |
| 11426 | Healthspan | GCST007406 | 7.88e-05 |
| 11427 | Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitor | UKBB00000706 | 7.82e-05 |
| 11428 | Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitor | UKBB00000694 | 7.82e-05 |
| 11429 | Systolic blood pressure (BMI unadjusted) | GCST90335162 | 7.81e-05 |
| 11430 | IDP T1 FAST ROIs L cerebellum crus I | GCST90002569 | 7.80e-05 |
| 11431 | STX6 levels | GCST90470774 | 7.80e-05 |
| 11432 | IRAK1/SPRY2 ratio | GCST90315196 | 7.75e-05 |
| 11433 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | GCST90320825 | 7.74e-05 |
| 11434 | HippSubfield rh volume GC-ML-DG-head | GCST90002701 | 7.73e-05 |
| 11435 | Chronic iridocyclitis | FING00000287 | 7.69e-05 |
| 11436 | SPOCK1 levels | GCST90470730 | 7.69e-05 |
| 11437 | CCL11/CCL2 ratio | GCST90313672 | 7.68e-05 |
| 11438 | MED18/ZBTB16 ratio | GCST90315416 | 7.63e-05 |
| 11439 | BA-exvivo lh area BA2 | GCST90003208 | 7.59e-05 |
| 11440 | AAMDC levels | GCST90468186 | 7.59e-05 |
| 11441 | FOXO1/NUB1 ratio | GCST90314874 | 7.57e-05 |
| 11442 | CCDC50 levels | GCST90468561 | 7.55e-05 |
| 11443 | aseg rh intensity Pallidum | GCST90003785 | 7.54e-05 |
| 11444 | Biological Mother: High blood pressure | GCST90475490 | 7.47e-05 |
| 11445 | BTN2A1/SPINT2 ratio | GCST90313550 | 7.46e-05 |
| 11446 | CD83/IL12A_IL12B ratio | GCST90313905 | 7.45e-05 |
| 11447 | Takes medication for high blood pressure? | GCST90475216 | 7.44e-05 |
| 11448 | aparc-DKTatlas lh area postcentral | GCST90003254 | 7.42e-05 |
| 11449 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024197 | 7.40e-05 |
| 11450 | Separation of retinal layers (serosa) | FING00001292 | 7.38e-05 |
| 11451 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T431 | ECGA000431 | 7.37e-05 |
| 11452 | AGRN levels | GCST90468255 | 7.33e-05 |
| 11453 | Childhood body mass index | GCST90002409 | 7.28e-05 |
| 11454 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditions | UKBB00000100 | 7.25e-05 |
| 11455 | UPB1 levels | GCST90471013 | 7.20e-05 |
| 11456 | Hypertension | GCST90086092 | 7.19e-05 |
| 11457 | Benign neoplasm: Rectum | FING00000196 | 7.13e-05 |
| 11458 | SRPK2/VASH1 ratio | GCST90315886 | 7.12e-05 |
| 11459 | Non-cancer illness code, self-reported - asthma | Medical conditions | UKBB00000506 | 7.12e-05 |
| 11460 | POMC levels | GCST90470284 | 6.98e-05 |
| 11461 | CCL20 levels | GCST90468572 | 6.98e-05 |
| 11462 | REN levels | GCST90470454 | 6.98e-05 |
| 11463 | aparc-DKTatlas rh area parsopercularis | GCST90003281 | 6.96e-05 |
| 11464 | MZB1 levels | GCST90469987 | 6.96e-05 |
| 11465 | SPINK1 levels | GCST90470721 | 6.96e-05 |
| 11466 | Rubneribacter sp002159915 abundance in stool | GCST90032541 | 6.96e-05 |
| 11467 | IDP dMRI ProbtrackX L1 cgh l | GCST90004252 | 6.95e-05 |
| 11468 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T436 | ECGA000436 | 6.95e-05 |
| 11469 | MPIG6B/PDGFB ratio | GCST90315482 | 6.94e-05 |
| 11470 | TNFSF13B levels | GCST90470920 | 6.93e-05 |
| 11471 | GNLY/GZMA ratio | GCST90314949 | 6.93e-05 |
| 11472 | Ground coffee consumption | GCST90132976 | 6.88e-05 |
| 11473 | DBNL/EDAR ratio | GCST90314416 | 6.82e-05 |
| 11474 | Esophagitis, GERD and related diseases | digestive | UKBB00000208 | 6.80e-05 |
| 11475 | F-coffee/alcohol liking (derived food-liking factor) | GCST90094737 | 6.79e-05 |
| 11476 | Number of days/week of vigorous physical activity 10+ minutes | Physical activity | UKBB00000534 | 6.78e-05 |
| 11477 | SNAP23/SNAP29 ratio | GCST90315855 | 6.76e-05 |
| 11478 | MEPE/SOST ratio | GCST90315420 | 6.72e-05 |
| 11479 | CLEC4C levels | GCST90468772 | 6.68e-05 |
| 11480 | CA9/CBLIF ratio | GCST90313595 | 6.64e-05 |
| 11481 | IDP dMRI ProbtrackX L3 ptr l | GCST90004319 | 6.63e-05 |
| 11482 | Duration walking for pleasure | Physical activity | UKBB00000203 | 6.54e-05 |
| 11483 | PLXNA4/SPRY2 ratio | GCST90315687 | 6.54e-05 |
| 11484 | Oral glucose tolerance test-2h | GCST90566423 | 6.51e-05 |
| 11485 | Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels | GCST90200118 | 6.46e-05 |
| 11486 | Lung cancer | GCST90018655 | 6.44e-05 |
| 11487 | Physical activity | GCST90093323 | 6.43e-05 |
| 11488 | Skin colour | Sun exposure | UKBB00000773 | 6.40e-05 |
| 11489 | Biological Father: Coronary Artery / Coronary Heart Disease | GCST90475241 | 6.39e-05 |
| 11490 | F-strong alcohol liking (derived food-liking factor) | GCST90094850 | 6.36e-05 |
| 11491 | CNST/DOK2 ratio | GCST90314157 | 6.34e-05 |
| 11492 | Secondary hypothyroidism (PheCode 244.1) | GCST90475649 | 6.27e-05 |
| 11493 | Job involves mainly walking or standing | Employment | UKBB00000384 | 6.26e-05 |
| 11494 | Alanine levels | GCST90497085 | 6.26e-05 |
| 11495 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T36 | ECGU000036 | 6.26e-05 |
| 11496 | REN levels | GCST90012038 | 6.26e-05 |
| 11497 | CDSN/NECTIN4 ratio | GCST90313998 | 6.25e-05 |
| 11498 | Type 1 diabetes | GCST90013791 | 6.20e-05 |
| 11499 | CASP8/PPP3R1 ratio | GCST90313654 | 6.17e-05 |
| 11500 | IDP T1 FAST ROIs R parietal operc cortex | GCST90002536 | 6.15e-05 |
| 11501 | WASF1 levels | GCST90471067 | 6.15e-05 |
| 11502 | SERPINC1 levels | GCST90470594 | 6.08e-05 |
| 11503 | Childhood asthma (age<16) (more control exclusions) | FING00000270 | 5.96e-05 |
| 11504 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditions | UKBB00000101 | 5.95e-05 |
| 11505 | Takes medication for skin cancer? | GCST90475190 | 5.95e-05 |
| 11506 | CRTAM levels | GCST90468871 | 5.95e-05 |
| 11507 | KLK8/NECTIN4 ratio | GCST90315258 | 5.85e-05 |
| 11508 | DNMBP/PTPN1 ratio | GCST90314517 | 5.78e-05 |
| 11509 | FCRL5/TNFRSF13B ratio | GCST90314805 | 5.78e-05 |
| 11510 | DTI autoptx L1 ifo r tract | GCST90385152 | 5.76e-05 |
| 11511 | Colon cancer/rectal cancer | GCST90475170 | 5.74e-05 |
| 11512 | FGF21 levels | GCST90274788 | 5.73e-05 |
| 11513 | Noninfectious disorders of lymphatic channels (PheCode 450) | GCST90476002 | 5.73e-05 |
| 11514 | Basal cell carcinoma | GCST90013410 | 5.71e-05 |
| 11515 | GNLY levels | GCST90469372 | 5.68e-05 |
| 11516 | Heart failure | GCST009541 | 5.65e-05 |
| 11517 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320589 | 5.54e-05 |
| 11518 | Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302718 | 5.52e-05 |
| 11519 | Other alveolar and parietoalveolar pneumonopathy (PheCode 504) | GCST90476033 | 5.50e-05 |
| 11520 | F11R/PARK7 ratio | GCST90314723 | 5.50e-05 |
| 11521 | IDP dMRI ProbtrackX MD unc l | GCST90004244 | 5.49e-05 |
| 11522 | Other diseases of intestine | Other diseases of intestines | UKBB00000605 | 5.49e-05 |
| 11523 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T284 | ECGU000284 | 5.48e-05 |
| 11524 | CKMT1A or CKMT1B levels | GCST90468760 | 5.48e-05 |
| 11525 | Primary angle-closure glaucoma | FING00001210 | 5.47e-05 |
| 11526 | Principal component-derived dietary pattern 9 | GCST90133014 | 5.45e-05 |
| 11527 | AZU1/RNASE3 ratio | GCST90313428 | 5.43e-05 |
| 11528 | METAP2/RILP ratio | GCST90315433 | 5.42e-05 |
| 11529 | GZMA levels | GCST90469423 | 5.42e-05 |
| 11530 | Systolic blood pressure (BMI adjusted) | GCST90335163 | 5.41e-05 |
| 11531 | FCRL6 levels | GCST90469209 | 5.36e-05 |
| 11532 | CD74/DLL1 ratio | GCST90313891 | 5.36e-05 |
| 11533 | Glomerular disorders in diseases classified elsewhere | FING00000582 | 5.35e-05 |
| 11534 | aparc-pial lh area precuneus | GCST90003165 | 5.34e-05 |
| 11535 | BCL2L11 levels | GCST90468430 | 5.31e-05 |
| 11536 | Lung cancer in never smokers | GCST90277434 | 5.31e-05 |
| 11537 | Hypothyroidism (PheCode 244) | GCST90475647 | 5.30e-05 |
| 11538 | Monocyte percentage of white cells | GCST90002394 | 5.30e-05 |
| 11539 | Systemic connective tissue disorders | FING00001350 | 5.24e-05 |
| 11540 | ORM1 levels | GCST90470129 | 5.19e-05 |
| 11541 | FOLH1 levels | GCST90241272 | 5.18e-05 |
| 11542 | Hypothyroidism | endocrine/metabolic | UKBB00000335 | 5.16e-05 |
| 11543 | Lower back pain or/and sciatica | FING00000731 | 5.14e-05 |
| 11544 | Crohn's disease of small intestine | FING00000369 | 5.14e-05 |
| 11545 | SELPLG levels | GCST90470568 | 5.13e-05 |
| 11546 | CC2D1A/STAMBP ratio | GCST90313664 | 5.12e-05 |
| 11547 | HRG levels | GCST90469476 | 5.11e-05 |
| 11548 | Tryptophan betaine levels | GCST90199819 | 5.09e-05 |
| 11549 | Total lipid levels in IDL | GCST90132633 | 5.09e-05 |
| 11550 | CRADD/EDAR ratio | GCST90314235 | 5.09e-05 |
| 11551 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 116) | GCST90320935 | 5.09e-05 |
| 11552 | CD300LF levels | GCST90468622 | 5.07e-05 |
| 11553 | Prescriptions - thiazide diuretic|diuretic | UKBB00000704 | 5.04e-05 |
| 11554 | GNE levels | GCST90469370 | 5.01e-05 |
| 11555 | DOK2 levels | GCST90469029 | 4.95e-05 |
| 11556 | KIR2DL2 levels | GCST90469684 | 4.94e-05 |
| 11557 | FGF2 levels | GCST90469224 | 4.92e-05 |
| 11558 | POSTN levels | GCST90470288 | 4.91e-05 |
| 11559 | SCGN levels | GCST90470544 | 4.90e-05 |
| 11560 | Kela-code for severe mental illness | FING00000707 | 4.90e-05 |
| 11561 | CRYGD levels | GCST90468876 | 4.89e-05 |
| 11562 | X-24406 metabolite level | GCST90616789 | 4.89e-05 |
| 11563 | FLT4/KDR ratio | GCST90314861 | 4.87e-05 |
| 11564 | Moderate to vigorous physical activity duration | GCST90061422 | 4.87e-05 |
| 11565 | VCAM1 levels | GCST90243317 | 4.87e-05 |
| 11566 | AARSD1/PIK3AP1 ratio | GCST90313129 | 4.84e-05 |
| 11567 | aparc-DKTatlas rh volume precentral | GCST90002915 | 4.83e-05 |
| 11568 | aparc-a2009s lh area S-orbital-H-Shaped | GCST90003360 | 4.81e-05 |
| 11569 | Anaphylactic shock due to adverse effect of correct drug or medication properly administered | FING00000084 | 4.80e-05 |
| 11570 | Myasthenia gravis | GCST90093061 | 4.79e-05 |
| 11571 | HGF/MMP9 ratio | GCST90315056 | 4.78e-05 |
| 11572 | Restless legs syndrome (PheCode 327.71) | GCST90475829 | 4.78e-05 |
| 11573 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T221 | ECGA000221 | 4.76e-05 |
| 11574 | Skin elastin (cheek, R5) | GCST90502787 | 4.72e-05 |
| 11575 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000435 | 4.71e-05 |
| 11576 | Noninfective enteritis and colitis | FING00000881 | 4.70e-05 |
| 11577 | Nasal polyp | Other diseases of upper respiratory tract | UKBB00000493 | 4.64e-05 |
| 11578 | Obesity (PheCode 278.1) | GCST90475762 | 4.61e-05 |
| 11579 | CA2/UBAC1 ratio | GCST90313583 | 4.59e-05 |
| 11580 | OLR1 levels | GCST90012020 | 4.59e-05 |
| 11581 | Encounter for long-term (current) use of anticoagulants (PheCode 286.2) | GCST90475799 | 4.58e-05 |
| 11582 | ADIPOQ levels | GCST90293086 | 4.57e-05 |
| 11583 | aseg rh intensity Thalamus-Proper | GCST90003782 | 4.57e-05 |
| 11584 | Atrial septal defect | FING00000128 | 4.56e-05 |
| 11585 | Ever highly irritable/argumentative for 2 days | Mental health | UKBB00000219 | 4.52e-05 |
| 11586 | HLA-E levels | GCST90469459 | 4.49e-05 |
| 11587 | Inflammatory bowel disease | GCST90432182 | 4.48e-05 |
| 11588 | C1QL2 levels | GCST90468487 | 4.44e-05 |
| 11589 | MYOC/NOTCH3 ratio | GCST90315507 | 4.42e-05 |
| 11590 | Membranous nephropathy | GCST010006 | 4.42e-05 |
| 11591 | PRKG1 levels | GCST90470330 | 4.41e-05 |
| 11592 | S100A16 levels | GCST90470516 | 4.41e-05 |
| 11593 | EDAR/SPARC ratio | GCST90314588 | 4.41e-05 |
| 11594 | Dermatitis due to ingested food | FING00000403 | 4.38e-05 |
| 11595 | Intra-ocular pressure, corneal-compensated (left) | Intraocular pressure | UKBB00000374 | 4.36e-05 |
| 11596 | Plasma taurocholenate sulfate* levels in chronic kidney disease | GCST90266040 | 4.35e-05 |
| 11597 | HBEGF/LAT2 ratio | GCST90315032 | 4.34e-05 |
| 11598 | Primary biliary cholangitis | GCST90061440 | 4.32e-05 |
| 11599 | aseg lh intensity Cerebellum-Cortex | GCST90003767 | 4.32e-05 |
| 11600 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000440 | 4.32e-05 |
| 11601 | Diastolic blood pressure | GCST90472779 | 4.31e-05 |
| 11602 | Asthma | GCST90018575 | 4.30e-05 |
| 11603 | Essential hypertension | circulatory system | UKBB00000209 | 4.25e-05 |
| 11604 | Malignant melanoma of skin, excluding all cancers (controls excluding all cancers) | FING00000749 | 4.23e-05 |
| 11605 | Preeclampsia or other maternal hypertension (maternal genotype effect) | GCST90269904 | 4.21e-05 |
| 11606 | TSHB levels | GCST90470974 | 4.18e-05 |
| 11607 | PDCD1/TNFRSF8 ratio | GCST90315610 | 4.14e-05 |
| 11608 | FCRL5/LY96 ratio | GCST90314803 | 4.13e-05 |
| 11609 | Birth weight | Early life factors | UKBB00000095 | 4.13e-05 |
| 11610 | ABL1/DNMBP ratio | GCST90313149 | 4.12e-05 |
| 11611 | Poisoning by antibiotics | injuries & poisonings | UKBB00000653 | 4.11e-05 |
| 11612 | Dermatitis | FING00000401 | 4.10e-05 |
| 11613 | MYBPC1 levels | GCST90469969 | 4.08e-05 |
| 11614 | Hypertension | circulatory system | UKBB00000334 | 4.08e-05 |
| 11615 | aparc-Desikan lh thickness cuneus | GCST90003449 | 4.05e-05 |
| 11616 | Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions) | FING00000692 | 4.04e-05 |
| 11617 | IDP T1 FAST ROIs L cerebellum X | GCST90002587 | 4.01e-05 |
| 11618 | VSIG4 levels | GCST90471052 | 3.99e-05 |
| 11619 | GDNF levels | GCST90469323 | 3.98e-05 |
| 11620 | Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000439 | 3.98e-05 |
| 11621 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T41 | ECGU000041 | 3.98e-05 |
| 11622 | NID1/TIMP3 ratio | GCST90315543 | 3.96e-05 |
| 11623 | Age hay fever, rhinitis or eczema diagnosed | Medical conditions | UKBB00000015 | 3.96e-05 |
| 11624 | CTSZ levels | GCST90468918 | 3.96e-05 |
| 11625 | Mosaic chromosomal alteration of the Y chromosome | GCST90165289 | 3.95e-05 |
| 11626 | EDAR/ENO2 ratio | GCST90314574 | 3.94e-05 |
| 11627 | OCLN levels | GCST90470114 | 3.93e-05 |
| 11628 | Allergy/adverse effect of penicillin | injuries & poisonings | UKBB00000028 | 3.93e-05 |
| 11629 | Mean arterial pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000437 | 3.91e-05 |
| 11630 | EDAR/PRDX5 ratio | GCST90314583 | 3.88e-05 |
| 11631 | IDP dMRI ProbtrackX FA ptr l | GCST90003944 | 3.88e-05 |
| 11632 | PDGFA/PLA2G4A ratio | GCST90315615 | 3.87e-05 |
| 11633 | IDP dMRI TBSS L1 Cingulum hippocampus R | GCST90004111 | 3.83e-05 |
| 11634 | Melanocytic naevi of trunk | FING00000800 | 3.82e-05 |
| 11635 | FOXO1/IRAK4 ratio | GCST90314870 | 3.80e-05 |
| 11636 | Ceramide (d17:1/24:0) levels | GCST90024033 | 3.79e-05 |
| 11637 | CHAC2 levels | GCST90468736 | 3.77e-05 |
| 11638 | CDH15 levels | GCST90468668 | 3.77e-05 |
| 11639 | SKAP2 levels | GCST90470646 | 3.76e-05 |
| 11640 | Allergic disease (asthma, hay fever or eczema) | GCST005038 | 3.74e-05 |
| 11641 | Plasma X-24544 levels in chronic kidney disease | GCST90266757 | 3.74e-05 |
| 11642 | FASLG levels | GCST90469191 | 3.72e-05 |
| 11643 | Monocyte percentage | Blood count | UKBB00000480 | 3.71e-05 |
| 11644 | Lateral epicondylitis | FING00000715 | 3.70e-05 |
| 11645 | Lymphocyte count | GCST004627 | 3.68e-05 |
| 11646 | IL15/KLRD1 ratio | GCST90315149 | 3.68e-05 |
| 11647 | Volume of right cortico-amygdaloid transition area | GCST90474913 | 3.66e-05 |
| 11648 | EFNA4/TNFRSF10B ratio | GCST90314605 | 3.63e-05 |
| 11649 | Iridocyclitis | FING00000696 | 3.63e-05 |
| 11650 | Treatment/medication code - levothyroxine sodium | Medications | UKBB00000849 | 3.63e-05 |
| 11651 | FCRL2 levels | GCST90469206 | 3.63e-05 |
| 11652 | Diastolic blood pressure | GCST90310295 | 3.59e-05 |
| 11653 | FOLR2/HAVCR2 ratio | GCST90314865 | 3.57e-05 |
| 11654 | INPP1/NT5C3A ratio | GCST90315177 | 3.57e-05 |
| 11655 | Right-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302799 | 3.56e-05 |
| 11656 | Mean platelet volume during third trimester of pregnancy | GCST90302231 | 3.54e-05 |
| 11657 | BST2/MME ratio | GCST90313539 | 3.51e-05 |
| 11658 | Diastolic blood pressure (BMI adjusted) | GCST90335165 | 3.49e-05 |
| 11659 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T43 | ECGU000043 | 3.48e-05 |
| 11660 | IDP dMRI TBSS ISOVF Posterior thalamic radiation R | GCST90004505 | 3.47e-05 |
| 11661 | Varicose veins (PheCode 454) | GCST90476012 | 3.47e-05 |
| 11662 | aparc-Desikan lh volume precuneus | GCST90002792 | 3.47e-05 |
| 11663 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T65 | ECGA000065 | 3.46e-05 |
| 11664 | DTI TBSS L2 Medial lemniscus L | GCST90384485 | 3.46e-05 |
| 11665 | Prescriptions - calcium channel blocker|dihydropyridine|anti-hypertensive | UKBB00000673 | 3.44e-05 |
| 11666 | aparc-Desikan rh area parsopercularis | GCST90003124 | 3.44e-05 |
| 11667 | Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditions | UKBB00000513 | 3.43e-05 |
| 11668 | CD160/NCR1 ratio | GCST90313732 | 3.38e-05 |
| 11669 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T441 | ECGU000441 | 3.37e-05 |
| 11670 | Mean arterial pressure, automated reading | Cardiovascular measurement | UKBB00000433 | 3.37e-05 |
| 11671 | Milk chocolate liking | GCST90094801 | 3.36e-05 |
| 11672 | BECN1 levels | GCST90468438 | 3.36e-05 |
| 11673 | Moderate-to-vigorous intensity physical activity during leisure time | GCST90104341 | 3.35e-05 |
| 11674 | GZMB/IL15 ratio | GCST90315015 | 3.31e-05 |
| 11675 | PFKM levels | GCST90618802 | 3.29e-05 |
| 11676 | Hypothyroidism NOS (PheCode 244.4) | GCST90475653 | 3.29e-05 |
| 11677 | MUC2 levels | GCST90469965 | 3.26e-05 |
| 11678 | Mean arterial pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000438 | 3.23e-05 |
| 11679 | FHIT/GLOD4 ratio | GCST90314817 | 3.22e-05 |
| 11680 | Olsenella C abundance in stool | GCST90032493 | 3.22e-05 |
| 11681 | Capers liking | GCST90094724 | 3.22e-05 |
| 11682 | SPON2 levels | GCST90470732 | 3.22e-05 |
| 11683 | Systolic blood pressure | GCST90301695 | 3.20e-05 |
| 11684 | RHOC/TBCC ratio | GCST90315775 | 3.17e-05 |
| 11685 | neutrophil (absolute count, maximum, inv-norm transformed) | GCST90475526 | 3.17e-05 |
| 11686 | KITLG levels | GCST90012023 | 3.16e-05 |
| 11687 | IL12RB1 levels | GCST90469550 | 3.15e-05 |
| 11688 | aparc-a2009s rh area G-precuneus | GCST90003400 | 3.14e-05 |
| 11689 | CLEC4G/LGALS4 ratio | GCST90314120 | 3.13e-05 |
| 11690 | Ceramide (d16:1/24:0) levels | GCST90024027 | 3.12e-05 |
| 11691 | Diseases of middle ear and mastoid | FING00000427 | 3.12e-05 |
| 11692 | Obesity, other/unspecified | FING00000898 | 3.11e-05 |
| 11693 | Left-hemisphere visual network to right-hemisphere limbic network white-matter structural connectivity | GCST90302659 | 3.11e-05 |
| 11694 | CCL5/TACC3 ratio | GCST90313707 | 3.09e-05 |
| 11695 | Myocardial fractal dimension (slice 8) | GCST90000294 | 3.08e-05 |
| 11696 | CCL4 levels | GCST90468583 | 3.06e-05 |
| 11697 | CCL2 levels | GCST90468581 | 3.05e-05 |
| 11698 | CNST/ITGB1BP2 ratio | GCST90314158 | 3.02e-05 |
| 11699 | ICAM3 levels | GCST90469500 | 3.01e-05 |
| 11700 | Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditions | UKBB00000518 | 3.01e-05 |
| 11701 | Otitis externa, unspecified | FING00001129 | 3.00e-05 |
| 11702 | ITGB1BP2/TIA1 ratio | GCST90315222 | 2.99e-05 |
| 11703 | Left-hemisphere limbic network to right-hemisphere limbic network white-matter structural connectivity | GCST90302733 | 2.98e-05 |
| 11704 | Handedness (chirality/laterality) - Right-handed | Early life factors | UKBB00000303 | 2.97e-05 |
| 11705 | DTI TBSS L2 Cingulum hippocampus L | GCST90384513 | 2.96e-05 |
| 11706 | X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levels | GCST90243619 | 2.95e-05 |
| 11707 | Obesity | FING00000895 | 2.94e-05 |
| 11708 | Maximum heart rate during fitness test | ECG during exercise | UKBB00000431 | 2.93e-05 |
| 11709 | Age-related macular degeneration | GCST90086111 | 2.91e-05 |
| 11710 | ASS1 levels | GCST90468380 | 2.87e-05 |
| 11711 | SCG2 levels | GCST90470538 | 2.87e-05 |
| 11712 | Leisure/social activities - Other group activity | Social support | UKBB00000400 | 2.86e-05 |
| 11713 | Histidine levels | GCST90092830 | 2.86e-05 |
| 11714 | Monocyte percentage (UKB data field 30190) | GCST90468091 | 2.85e-05 |
| 11715 | SKAP1 levels | GCST90470645 | 2.81e-05 |
| 11716 | Macular degeneration, wet (PheCode 362.22) | GCST90475852 | 2.80e-05 |
| 11717 | Viral and other specified intestinal infections | FING00001432 | 2.80e-05 |
| 11718 | X-11550 levels | GCST90243648 | 2.77e-05 |
| 11719 | FADD/NFATC1 ratio | GCST90314771 | 2.75e-05 |
| 11720 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T35 | ECGU000035 | 2.73e-05 |
| 11721 | COL1A1 levels | GCST90240744 | 2.73e-05 |
| 11722 | Skin cancer | neoplasms | UKBB00000772 | 2.73e-05 |
| 11723 | ATP5IF1/HSPA1A ratio | GCST90313388 | 2.73e-05 |
| 11724 | aparc-a2009s rh volume S-parieto-occipital | GCST90003063 | 2.70e-05 |
| 11725 | KIR3DL1 levels | GCST90469687 | 2.69e-05 |
| 11726 | FYB1/PDGFB ratio | GCST90314912 | 2.68e-05 |
| 11727 | REG4 levels | GCST90470451 | 2.68e-05 |
| 11728 | IDP dMRI ProbtrackX FA fmi | GCST90003936 | 2.67e-05 |
| 11729 | NAP1L4 levels | GCST90469998 | 2.66e-05 |
| 11730 | N-acetylphenylalanine levels in chronic kidney disease | GCST90257537 | 2.66e-05 |
| 11731 | Lymphoid leukaemia (controls excluding all cancers) | FING00000741 | 2.65e-05 |
| 11732 | Disorder of skin and subcutaneous tissue NO (PheCode 689) | GCST90476169 | 2.63e-05 |
| 11733 | Hypothyroidism NOS | endocrine/metabolic | UKBB00000336 | 2.58e-05 |
| 11734 | Excessive hairiness | GCST006095 | 2.58e-05 |
| 11735 | CRKL/DBNL ratio | GCST90314263 | 2.58e-05 |
| 11736 | aparc-a2009s lh thickness G-precuneus | GCST90003632 | 2.57e-05 |
| 11737 | DBI/EDAR ratio | GCST90314408 | 2.57e-05 |
| 11738 | THBD levels | GCST90012048 | 2.54e-05 |
| 11739 | BA-exvivo lh volume BA2 | GCST90002836 | 2.51e-05 |
| 11740 | CD160/KLRB1 ratio | GCST90313731 | 2.50e-05 |
| 11741 | CAPS levels | GCST90468539 | 2.48e-05 |
| 11742 | Peripheral or central vertigo (PheCode 386.2) | GCST90475907 | 2.48e-05 |
| 11743 | Number of operations, self-reported | Operations | UKBB00000539 | 2.46e-05 |
| 11744 | Pain in joint (PheCode 745) | GCST90476262 | 2.46e-05 |
| 11745 | Volume of right accessory basal nucleus | GCST90475009 | 2.44e-05 |
| 11746 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320900 | 2.42e-05 |
| 11747 | FABP1 levels | GCST90469173 | 2.42e-05 |
| 11748 | Corneal dystrophy (PheCode 364.5) | GCST90475864 | 2.40e-05 |
| 11749 | Other hypothyroidism | Disorders of thyroid gland | UKBB00000611 | 2.40e-05 |
| 11750 | LY6D/WFDC12 ratio | GCST90315346 | 2.39e-05 |
| 11751 | Non-cancer illness code, self-reported - hiatus hernia | Medical conditions | UKBB00000515 | 2.38e-05 |
| 11752 | F-cake/biscuits liking (derived food-liking factor) | GCST90094722 | 2.38e-05 |
| 11753 | Medication for pain relief, constipation, heartburn - Omeprazole (e.g. Zanprol) | Medication | UKBB00000458 | 2.37e-05 |
| 11754 | Hypothyroidism, strict autoimmune | FING00000656 | 2.37e-05 |
| 11755 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T60 | ECGA000060 | 2.36e-05 |
| 11756 | PGR levels | GCST90470223 | 2.34e-05 |
| 11757 | PATE4 levels | GCST90242405 | 2.34e-05 |
| 11758 | C9 levels | GCST90468505 | 2.34e-05 |
| 11759 | Varicose veins of lower extremity, symptomtic (PheCode 454.11) | GCST90476014 | 2.34e-05 |
| 11760 | Methods of admission to hospital (recoded) - Elective admission: Waiting List | Summary Administration | UKBB00000463 | 2.33e-05 |
| 11761 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T34 | ECGU000034 | 2.32e-05 |
| 11762 | Optic cup area | GCST004137 | 2.31e-05 |
| 11763 | Other disorders of eyelid | FING00001026 | 2.30e-05 |
| 11764 | CCL8 levels | GCST90468586 | 2.29e-05 |
| 11765 | FUT3 levels | GCST90241216 | 2.29e-05 |
| 11766 | Glycerate levels | GCST90200290 | 2.29e-05 |
| 11767 | 1-stearoyl-GPE (18:0) levels | GCST90199772 | 2.28e-05 |
| 11768 | IDP dMRI TBSS OD Anterior limb of internal capsule L | GCST90004419 | 2.28e-05 |
| 11769 | Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary Operations | UKBB00000591 | 2.27e-05 |
| 11770 | aseg lh intensity Pallidum | GCST90003771 | 2.26e-05 |
| 11771 | DAG1/GP6 ratio | GCST90314375 | 2.22e-05 |
| 11772 | Medication use (drugs used in diabetes) | GCST90018761 | 2.21e-05 |
| 11773 | Body-mass index, inverse-rank normalized | FING00000222 | 2.15e-05 |
| 11774 | Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditions | UKBB00000098 | 2.14e-05 |
| 11775 | Leisure/social activities - Adult education class | Social support | UKBB00000398 | 2.12e-05 |
| 11776 | CCL18/RARRES2 ratio | GCST90313690 | 2.11e-05 |
| 11777 | GUSB levels | GCST90469421 | 2.08e-05 |
| 11778 | Ulcerative colitis (strict) with PSC | FING00001389 | 2.07e-05 |
| 11779 | Mean arterial pressure, automated reading | Cardiovascular measurement | UKBB00000434 | 2.06e-05 |
| 11780 | TIRAP levels | GCST90243032 | 2.06e-05 |
| 11781 | PIK3AP1/PSMG3 ratio | GCST90315651 | 2.04e-05 |
| 11782 | Treatment/medication code - amlodipine | Medications | UKBB00000840 | 2.04e-05 |
| 11783 | IDP dMRI ProbtrackX FA unc l | GCST90003950 | 2.03e-05 |
| 11784 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T46 | ECGU000046 | 2.02e-05 |
| 11785 | Valvular heart disease excluding rheumatic fever | FING00001414 | 2.02e-05 |
| 11786 | PPME1 levels | GCST90470298 | 2.02e-05 |
| 11787 | FABP4/SNCG ratio | GCST90314759 | 1.97e-05 |
| 11788 | IDP T1 FAST ROIs R postcent gyrus | GCST90002484 | 1.95e-05 |
| 11789 | YOD1 levels | GCST90471090 | 1.93e-05 |
| 11790 | DKK1/PDGFA ratio | GCST90314475 | 1.93e-05 |
| 11791 | Mean arterial pressure (BMI adjusted) | GCST90335169 | 1.90e-05 |
| 11792 | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | GCST90302766 | 1.89e-05 |
| 11793 | Diastolic blood pressure | GCST90301699 | 1.89e-05 |
| 11794 | Iron deficiency anemia secondary to blood loss (chronic) (PheCode 280.2) | GCST90475770 | 1.87e-05 |
| 11795 | Octadecenedioate (C18:1-DC) levels | GCST90200165 | 1.87e-05 |
| 11796 | Diseases of hair and hair follicles (PheCode 704) | GCST90476209 | 1.87e-05 |
| 11797 | CIAPIN1/SPARC ratio | GCST90314069 | 1.86e-05 |
| 11798 | Basal cell carcinoma (MTAG) | GCST90137411 | 1.86e-05 |
| 11799 | CA2/CA3 ratio | GCST90313576 | 1.86e-05 |
| 11800 | Erectile dysfunction | GCST006956 | 1.86e-05 |
| 11801 | X-21285 levels | GCST90200576 | 1.85e-05 |
| 11802 | Endometriosis of pelvic peritoneum | FING00000502 | 1.84e-05 |
| 11803 | DNER levels | GCST90274785 | 1.83e-05 |
| 11804 | neutrophil (fraction, mean, inv-norm transformed) | GCST90475538 | 1.81e-05 |
| 11805 | Mean arterial pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000436 | 1.80e-05 |
| 11806 | IDP T1 FAST ROIs L cerebellum V | GCST90002564 | 1.79e-05 |
| 11807 | Urinary tryptophan to urinary creatinine ratio | GCST90451748 | 1.78e-05 |
| 11808 | Glaucoma (PheCode 365) | GCST008373 | 1.77e-05 |
| 11809 | MED18/TACC3 ratio | GCST90315414 | 1.76e-05 |
| 11810 | aseg rh volume Caudate | GCST90002638 | 1.75e-05 |
| 11811 | Treatment/medication code - bendroflumethiazide | Medications | UKBB00000843 | 1.72e-05 |
| 11812 | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | GCST90302765 | 1.70e-05 |
| 11813 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502074 | 1.68e-05 |
| 11814 | aparc-a2009s lh volume G-precuneus | GCST90002954 | 1.68e-05 |
| 11815 | ICD10 O20: Haemorrhage in early pregnancy | GCST90454235 | 1.67e-05 |
| 11816 | EDAR/IRAK4 ratio | GCST90314579 | 1.67e-05 |
| 11817 | Tyrosine levels | GCST90243425 | 1.66e-05 |
| 11818 | PDGFA/SNAP23 ratio | GCST90315619 | 1.64e-05 |
| 11819 | Noninflammatory disorders of female genital tract | FING00000882 | 1.63e-05 |
| 11820 | Multi-trait sum score | GCST90270117 | 1.62e-05 |
| 11821 | RGMA/RGMB ratio | GCST90315769 | 1.62e-05 |
| 11822 | aparc-Desikan lh thickness precuneus | GCST90003469 | 1.61e-05 |
| 11823 | Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions) | FING00000694 | 1.60e-05 |
| 11824 | Phosphatidylcholine acyl-alkyl C36:4 levels | GCST90240072 | 1.59e-05 |
| 11825 | Mouth/teeth dental problems - Dentures | Mouth | UKBB00000486 | 1.57e-05 |
| 11826 | Oily fish intake | Diet | UKBB00000547 | 1.57e-05 |
| 11827 | Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditions | UKBB00000898 | 1.55e-05 |
| 11828 | HippSubfield rh volume hippocampal-fissure | GCST90002694 | 1.53e-05 |
| 11829 | RNF5 levels | GCST90470488 | 1.52e-05 |
| 11830 | Mean arterial pressure (BMI unadjusted) | GCST90335168 | 1.51e-05 |
| 11831 | Acute appendicitis | FING00000017 | 1.51e-05 |
| 11832 | IL18 levels | GCST90428411 | 1.50e-05 |
| 11833 | Other heart diseases | FING00001057 | 1.50e-05 |
| 11834 | DTI autoptx MD unc r tract | GCST90385246 | 1.50e-05 |
| 11835 | Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skin | UKBB00000613 | 1.45e-05 |
| 11836 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T67 | ECGA000067 | 1.45e-05 |
| 11837 | CA5A/KRT18 ratio | GCST90313592 | 1.44e-05 |
| 11838 | CCN2/SERPINB1 ratio | GCST90313715 | 1.44e-05 |
| 11839 | GP2/LGALS4 ratio | GCST90314960 | 1.43e-05 |
| 11840 | IDP dMRI TBSS L2 Genu of corpus callosum | GCST90004125 | 1.43e-05 |
| 11841 | Essential hypertension (PheCode 401.1) | GCST90475922 | 1.42e-05 |
| 11842 | Primary Raynaud’s phenomenon | GCST90271714 | 1.41e-05 |
| 11843 | CASP3/PDGFB ratio | GCST90313638 | 1.39e-05 |
| 11844 | IL16 levels | GCST90241596 | 1.39e-05 |
| 11845 | MEP1A levels | GCST90469887 | 1.39e-05 |
| 11846 | ATP5IF1/FXN ratio | GCST90313386 | 1.39e-05 |
| 11847 | Frailty (Factor 6 - Disability) | GCST90624052 | 1.37e-05 |
| 11848 | APOL1 levels | GCST90468341 | 1.37e-05 |
| 11849 | DYNLT1 levels | GCST90469057 | 1.36e-05 |
| 11850 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25) | GCST90320588 | 1.36e-05 |
| 11851 | Left-hemisphere control network to right-hemisphere default mode network white-matter structural connectivity | GCST90302751 | 1.35e-05 |
| 11852 | IRAK1/NFATC1 ratio | GCST90315194 | 1.34e-05 |
| 11853 | PLA2G15 levels | GCST90470245 | 1.33e-05 |
| 11854 | Pizza liking | GCST90094810 | 1.33e-05 |
| 11855 | Treatment/medication code - salbutamol | Medications | UKBB00000857 | 1.32e-05 |
| 11856 | Illnesses of father - None of the above (group 2) | Family history | UKBB00000346 | 1.31e-05 |
| 11857 | wg lh intensity-contrast lingual | GCST90003804 | 1.30e-05 |
| 11858 | COMT levels | GCST90468828 | 1.30e-05 |
| 11859 | SCN4B levels | GCST90470551 | 1.30e-05 |
| 11860 | neutrophil (fraction, minimum, inv-norm transformed) | GCST90475541 | 1.29e-05 |
| 11861 | GBP1 levels | GCST90469311 | 1.28e-05 |
| 11862 | CASP3/PDGFA ratio | GCST90313637 | 1.28e-05 |
| 11863 | CCL3 levels | GCST90468582 | 1.28e-05 |
| 11864 | Left-hemisphere limbic network to putamen white-matter structural connectivity | GCST90302738 | 1.24e-05 |
| 11865 | CDKN2D/MANF ratio | GCST90313989 | 1.24e-05 |
| 11866 | Melanocytic naevi, other sites/unspecified | FING00000802 | 1.21e-05 |
| 11867 | F2R/SPINT2 ratio | GCST90314737 | 1.21e-05 |
| 11868 | Other acute lower respiratory infections | FING00000921 | 1.21e-05 |
| 11869 | Leisure/social activities - Sports club or gym | Social support | UKBB00000402 | 1.21e-05 |
| 11870 | Melanoma in situ (controls excluding all cancers) | FING00000803 | 1.21e-05 |
| 11871 | Seborrheic dermatitis (PheCode 690.1) | GCST90476171 | 1.21e-05 |
| 11872 | Age-related macular degeneration (whether dry or wet) | FING00000047 | 1.21e-05 |
| 11873 | Cancer within the respiratory system (PheCode 165) | GCST90475571 | 1.21e-05 |
| 11874 | Coffee max liking | GCST90094739 | 1.21e-05 |
| 11875 | FCRL6/KLRD1 ratio | GCST90314807 | 1.20e-05 |
| 11876 | GLOD4/S100A4 ratio | GCST90314944 | 1.19e-05 |
| 11877 | Lymphocyte percentage of white cells | GCST004632 | 1.19e-05 |
| 11878 | Erythematosquamous dermatosis (PheCode 690) | GCST90476170 | 1.19e-05 |
| 11879 | Basophil percentage of granulocytes | GCST004634 | 1.19e-05 |
| 11880 | Alkylphosphatidylcholine (O-34:1) levels | GCST90025551 | 1.18e-05 |
| 11881 | Principal component-derived dietary pattern 45 | GCST90133050 | 1.17e-05 |
| 11882 | aparc-DKTatlas lh area precuneus | GCST90003257 | 1.16e-05 |
| 11883 | LILRB4 levels | GCST90469778 | 1.16e-05 |
| 11884 | SERPINE2 levels | GCST90470597 | 1.15e-05 |
| 11885 | Monocyte percentage of white cells | GCST004609 | 1.15e-05 |
| 11886 | CCL18 levels | GCST90468570 | 1.14e-05 |
| 11887 | Volume of right anterior amygdaloid area | GCST90475003 | 1.14e-05 |
| 11888 | HAVCR2/TNFRSF1B ratio | GCST90315030 | 1.13e-05 |
| 11889 | Ceramide (d17:1/22:0) levels | GCST90024032 | 1.13e-05 |
| 11890 | EDAR/SNAP23 ratio | GCST90314587 | 1.12e-05 |
| 11891 | CCL22 levels | GCST90468574 | 1.12e-05 |
| 11892 | Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555) | GCST90476065 | 1.10e-05 |
| 11893 | Vascular/heart problems diagnosed by doctor - None of the above | Medical conditions | UKBB00000899 | 1.09e-05 |
| 11894 | T1 FreeSurfer BA rh BA4p exvivo area | GCST90385552 | 1.09e-05 |
| 11895 | ATP5IF1/DECR1 ratio | GCST90313382 | 1.09e-05 |
| 11896 | Body mass index | GCST90502912 | 1.06e-05 |
| 11897 | TXLNA levels | GCST90470989 | 1.06e-05 |
| 11898 | BLVRB/CA3 ratio | GCST90313523 | 1.03e-05 |
| 11899 | KRT5 levels | GCST90469718 | 1.03e-05 |
| 11900 | White blood cell count (basophil) | GCST004618 | 1.02e-05 |
| 11901 | Eczema | GCST90468126 | 1.01e-05 |
| 11902 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T222 | ECGA000222 | 1.00e-05 |
| 11903 | Fractures | GCST006980 | 1.00e-05 |
| 11904 | Milk type used - Full cream | Diet | UKBB00000468 | 9.99e-06 |
| 11905 | IDP T1 FAST ROIs R precentral gyrus | GCST90002464 | 9.97e-06 |
| 11906 | Right-hemisphere visual network to accumbens white-matter structural connectivity | GCST90302787 | 9.92e-06 |
| 11907 | Gastric ulcer | GCST90018631 | 9.87e-06 |
| 11908 | Psoriasis | GCST90019016 | 9.82e-06 |
| 11909 | Lymphocyte count (UKB data field 30120) | GCST90468082 | 9.69e-06 |
| 11910 | Lymphocyte count | GCST90025984 | 9.64e-06 |
| 11911 | Suppurative and unspecified otitis media | FING00001346 | 9.55e-06 |
| 11912 | NTN1 levels | GCST90242047 | 9.39e-06 |
| 11913 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T223 | ECGA000223 | 9.36e-06 |
| 11914 | Follicular lymphoma, hilmo (controls excluding all cancers) | FING00000548 | 9.30e-06 |
| 11915 | Primary sclerosing cholangitis | GCST004030 | 9.26e-06 |
| 11916 | Hypothyroidism | GCST90319320 | 9.23e-06 |
| 11917 | Systolic blood pressure (standard GWA) | GCST90267304 | 9.22e-06 |
| 11918 | IDP T1 FAST ROIs L cerebellum VIIb | GCST90002575 | 9.17e-06 |
| 11919 | Disorders of the thyroid gland | FING00000463 | 9.08e-06 |
| 11920 | LEG1 levels | GCST90469753 | 9.06e-06 |
| 11921 | IDP dMRI ProbtrackX L3 fmi | GCST90004311 | 9.01e-06 |
| 11922 | GZMA/TNFRSF8 ratio | GCST90315014 | 8.92e-06 |
| 11923 | Gestational age at birth (child effect) | GCST90268421 | 8.88e-06 |
| 11924 | Alcohol liking | GCST90094688 | 8.81e-06 |
| 11925 | Physical activity (Principal component 2) | GCST90061423 | 8.73e-06 |
| 11926 | Neoplasm of uncertain behavior of skin (PheCode 173) | GCST90475585 | 8.61e-06 |
| 11927 | FCRL5 levels | GCST90469208 | 8.56e-06 |
| 11928 | Alcohol-induced chronic pancreatitis | FING00000055 | 8.56e-06 |
| 11929 | ITGB1BP2/MITD1 ratio | GCST90315214 | 8.56e-06 |
| 11930 | CD302/IL12A_IL12B ratio | GCST90313806 | 8.45e-06 |
| 11931 | Other Crohn's disease | FING00000992 | 8.29e-06 |
| 11932 | IDP dMRI ProbtrackX MD ptr l | GCST90004238 | 8.26e-06 |
| 11933 | lymphocyte (fraction, minimum, inv-norm transformed) | GCST90475438 | 8.26e-06 |
| 11934 | Cream liking | GCST90094746 | 8.23e-06 |
| 11935 | Tryptophan levels | GCST90243403 | 8.03e-06 |
| 11936 | OLR1/PLAUR ratio | GCST90315584 | 7.89e-06 |
| 11937 | Lymphocyte count | GCST90002316 | 7.87e-06 |
| 11938 | Other bacterial intestinal infections | FING00000969 | 7.87e-06 |
| 11939 | Blood cell traits latent factor 23 (white cell) | GCST90559265 | 7.84e-06 |
| 11940 | Diastolic blood pressure (BMI unadjusted) | GCST90335164 | 7.82e-06 |
| 11941 | PPIE levels | GCST90242217 | 7.74e-06 |
| 11942 | EDAR/ITGB1BP2 ratio | GCST90314580 | 7.74e-06 |
| 11943 | Sleep related movement disorders (PheCode 327.7) | GCST90475827 | 7.73e-06 |
| 11944 | Diarrhoea and gastroenteritis of presumed infectious origin | FING00000420 | 7.64e-06 |
| 11945 | EDAR/SERPINB1 ratio | GCST90314586 | 7.60e-06 |
| 11946 | Blood cell traits latent factor 16 (white cell) | GCST90559258 | 7.59e-06 |
| 11947 | Non-cancer illness code, self-reported - hypertension | Medical conditions | UKBB00000517 | 7.58e-06 |
| 11948 | SLIT2 levels | GCST90470668 | 7.47e-06 |
| 11949 | Lymphocyte count | GCST90002388 | 7.40e-06 |
| 11950 | Use of dietary supplements (confirmatory factor analysis Factor 13) | GCST90309347 | 7.37e-06 |
| 11951 | DTI TBSS L2 Genu of corpus callosum | GCST90384478 | 7.32e-06 |
| 11952 | ITGB1BP2/MED18 ratio | GCST90315213 | 7.24e-06 |
| 11953 | GP6/SCARF1 ratio | GCST90314969 | 7.18e-06 |
| 11954 | Blood cell traits latent factor 18 (platelet) | GCST90559260 | 7.16e-06 |
| 11955 | Hypothyroidism | GCST90204167 | 7.14e-06 |
| 11956 | MYL3 levels | GCST90469977 | 7.08e-06 |
| 11957 | Sensorineural hearing loss | FING00001291 | 7.04e-06 |
| 11958 | SMPD3 levels | GCST90470685 | 7.02e-06 |
| 11959 | Hypertension | GCST90468135 | 6.98e-06 |
| 11960 | KIF22 levels | GCST90469682 | 6.98e-06 |
| 11961 | Mean platelet volume during first trimester of pregnancy | GCST90302229 | 6.97e-06 |
| 11962 | Doctor diagnosed hayfever or allergic rhinitis | Medical information | UKBB00000192 | 6.86e-06 |
| 11963 | Blood cell traits latent factor 5 (platelet) | GCST90559247 | 6.85e-06 |
| 11964 | Alkylphosphatidylcholine (O-32:1) levels | GCST90024923 | 6.76e-06 |
| 11965 | IDP dMRI ProbtrackX L1 ilf r | GCST90004261 | 6.64e-06 |
| 11966 | CLEC4D levels | GCST90468773 | 6.55e-06 |
| 11967 | Type 2 diabetes with renal manifestations (PheCode 250.22) | GCST90475670 | 6.49e-06 |
| 11968 | Types of physical activity in last 4 weeks - None of the above | Physical activity | UKBB00000872 | 6.44e-06 |
| 11969 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T258 | ECGA000258 | 6.41e-06 |
| 11970 | GFRA2/IL12A_IL12B ratio | GCST90314925 | 6.38e-06 |
| 11971 | CEP43/TIA1 ratio | GCST90314021 | 6.37e-06 |
| 11972 | MSTN levels | GCST90469953 | 6.34e-06 |
| 11973 | Other systemic involvement of connective tissue (FG) | FING00001116 | 6.23e-06 |
| 11974 | lymphocyte (absolute count, maximum, inv-norm transformed) | GCST90475423 | 6.21e-06 |
| 11975 | ACY1 levels | GCST90468212 | 6.18e-06 |
| 11976 | ADM levels | GCST90468246 | 6.11e-06 |
| 11977 | NFATC1 levels | GCST90470033 | 6.08e-06 |
| 11978 | Lifetime number of sexual partners | Sexual factors | UKBB00000406 | 6.07e-06 |
| 11979 | Type 1 diabetes | GCST90000529 | 6.06e-06 |
| 11980 | Personality disorders (more control exclusions) | FING00001163 | 6.04e-06 |
| 11981 | CRTAP levels | GCST90468872 | 6.04e-06 |
| 11982 | DNM3 levels | GCST90469022 | 6.04e-06 |
| 11983 | Fasting glucose | GCST90002232 | 6.00e-06 |
| 11984 | Telomere length (principal component 1) | GCST90435144 | 5.93e-06 |
| 11985 | SLAMF7 levels | GCST90470651 | 5.93e-06 |
| 11986 | CASP8/RILP ratio | GCST90313657 | 5.81e-06 |
| 11987 | IL12A_IL12B/LAG3 ratio | GCST90315147 | 5.75e-06 |
| 11988 | EBAG9/TBCC ratio | GCST90314568 | 5.75e-06 |
| 11989 | EDAR/ERBIN ratio | GCST90314575 | 5.66e-06 |
| 11990 | Neutrophil percentage of white cells | GCST90002399 | 5.62e-06 |
| 11991 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119) | GCST90320938 | 5.61e-06 |
| 11992 | Hypertension (PheCode 401) | GCST90475919 | 5.51e-06 |
| 11993 | FUT8/PDGFA ratio | GCST90314890 | 5.50e-06 |
| 11994 | TMSB10/TXNRD1 ratio | GCST90315925 | 5.46e-06 |
| 11995 | Acute appendicitis, with complications | FING00000019 | 5.39e-06 |
| 11996 | aseg lh volume Caudate | GCST90002621 | 5.37e-06 |
| 11997 | Treatment/medication code - lansoprazole | Medications | UKBB00000848 | 5.34e-06 |
| 11998 | Number of non-cancer illnesses (weighted GWA) | GCST90267291 | 5.30e-06 |
| 11999 | General happiness | Happiness and subjective well-being | UKBB00000280 | 5.27e-06 |
| 12000 | aparc-a2009s rh area S-postcentral | GCST90003437 | 5.25e-06 |